Intestine-Specific Mttp Deletion Decreases Mortality and Prevents Sepsis-Induced Intestinal Injury in a Murine Model of Pseudomonas aeruginosa Pneumonia

被引:17
作者
Dominguez, Jessica A. [2 ]
Xie, Yan [1 ]
Dunne, W. Michael [3 ]
Yoseph, Benyam P. [4 ,5 ]
Burd, Eileen M. [6 ]
Coopersmith, Craig M. [4 ,5 ]
Davidson, Nicholas O. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[4] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA USA
[5] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
[6] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
TRIGLYCERIDE TRANSFER PROTEIN; CRITICAL-CARE MEDICINE; GUT-LYMPH HYPOTHESIS; EPITHELIAL APOPTOSIS; IMPROVES SURVIVAL; SEPTIC SHOCK; ORGAN DYSFUNCTION; DEFICIENT MICE; HOST-DEFENSE; IN-VIVO;
D O I
10.1371/journal.pone.0049159
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: The small intestine plays a crucial role in the pathophysiology of sepsis and has been referred to as the "motor'' of the systemic inflammatory response. One proposed mechanism is that toxic gut-derived lipid factors, transported in mesenteric lymph, induce systemic injury and distant organ failure. However, the pathways involved are yet to be defined and the role of intestinal chylomicron assembly and secretion in transporting these lipid factors is unknown. Here we studied the outcome of sepsis in mice with conditional, intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO), which exhibit a block in chylomicron assembly together with lipid malabsorption. Methodology/Principal Findings: Mttp-IKO mice and controls underwent intratracheal injection with either Pseudomonas aeruginosa or sterile saline. Mttp-IKO mice exhibited decreased seven-day mortality, with 0/20 (0%) dying compared to 5/17 (29%) control mice (p<0.05). This survival advantage in Mttp-IKO mice, however, was not associated with improvements in pulmonary bacterial clearance or neutrophil infiltration. Rather, Mttp-IKO mice exhibited protection against sepsis-associated decreases in villus length and intestinal proliferation and were also protected against increased intestinal apoptosis, both central features in control septic mice. Serum IL-6 levels, a major predictor of mortality in human and mouse models of sepsis, were elevated 8-fold in septic control mice but remained unaltered in septic Mttp-IKO mice. Serum high density lipoprotein (HDL) levels were reduced in septic control mice but were increased in septic Mttp-IKO mice. The decreased levels of HDL were associated with decreased hepatic expression of apolipoprotein A1 in septic control mice. Conclusions/Significance: These studies suggest that strategies directed at blocking intestinal chylomicron secretion may attenuate the progression and improve the outcome of sepsis through effects mediated by metabolic and physiological adaptations in both intestinal and hepatic lipid flux. Citation: Dominguez JA, Xie Y, Dunne WM, Yoseph BP, Burd EM, et al. (2012) Intestine-Specific Mttp Deletion Decreases Mortality and Prevents Sepsis-Induced Intestinal Injury in a Murine Model of Pseudomonas aeruginosa Pneumonia. PLoS ONE 7(11): e49159. doi:10.1371/journal.pone.0049159
引用
收藏
页数:13
相关论文
共 51 条
[1]
Pseudomonas aeruginosa utilises its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii [J].
Abd, Hadi ;
Wretlind, Bengt ;
Saeed, Amir ;
Idsund, Eva ;
Hultenby, Kjell ;
Sandstrom, Gunnar .
JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2008, 55 (03) :235-243
[2]
Triglyceride-rich lipoproteins as agents of innate immunity [J].
Barcia, AM ;
Harris, HW .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S498-S503
[3]
The role of the microsomal triglygeride transfer protein in abetalipoproteinemia [J].
Berriot-Varoqueaux, N ;
Aggerbeck, LP ;
Samson-Bouma, ME ;
Wetterau, JR .
ANNUAL REVIEW OF NUTRITION, 2000, 20 :663-697
[4]
Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: A cohort study in septic shock patients [J].
Bilbault, Pascal ;
Lavaux, Thomas ;
Launoy, Anne ;
Gaub, Marie P. ;
Meyer, Nicolas ;
Oudet, Pierre ;
Pottecher, Thierry ;
Jaeger, Albert ;
Schneider, Francis .
CRITICAL CARE MEDICINE, 2007, 35 (01) :69-75
[5]
Tissue-specific induction of intestinal ABCA1 expression with a liver x receptor agonist raises plasma HDL cholesterol levels [J].
Brunham, Liam R. ;
Kruit, Janine K. ;
Pape, Terry D. ;
Parks, John S. ;
Kuipers, Folkert ;
Hayden, Michael R. .
CIRCULATION RESEARCH, 2006, 99 (07) :672-674
[6]
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo [J].
Brunham, LR ;
Kruit, JK ;
Iqbal, J ;
Fievet, C ;
Timmins, JM ;
Pape, TD ;
Coburn, BA ;
Bissada, N ;
Staels, B ;
Groen, AK ;
Hussain, MM ;
Parks, JS ;
Kuipers, F ;
Hayden, MR .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (04) :1052-1062
[7]
Intestinal crosstalk: A new paradigm for understanding the gut as the "motor" of critical illness [J].
Clark, Jessica A. ;
Coopersmith, Craig M. .
SHOCK, 2007, 28 (04) :384-393
[8]
Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis [J].
Clark, Jessica A. ;
Gan, Heng ;
Samocha, Alexandr J. ;
Fox, Amy C. ;
Buchman, Timothy G. ;
Coopersmith, Craig M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 297 (03) :G471-G479
[9]
Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest [J].
Coopersmith, CM ;
Stromberg, PE ;
Davis, CG ;
Dunne, WM ;
Amiot, DM ;
Karl, IE ;
Hotchkiss, RS ;
Buchman, TG .
CRITICAL CARE MEDICINE, 2003, 31 (06) :1630-1637
[10]
Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice [J].
Coopersmith, CM ;
Chang, KC ;
Swanson, PE ;
Tinsley, KW ;
Stromberg, PE ;
Buchman, TG ;
Karl, IE ;
Hotchkiss, RS .
CRITICAL CARE MEDICINE, 2002, 30 (01) :195-201